These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1694202)

  • 1. The complement SC5b-9 complex mediates cell adhesion through a vitronectin receptor.
    Biesecker G
    J Immunol; 1990 Jul; 145(1):209-14. PubMed ID: 1694202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-3-dependent mast cells attach to plate-bound vitronectin. Demonstration of augmented proliferation in response to signals transduced via cell surface vitronectin receptors.
    Bianchine PJ; Burd PR; Metcalfe DD
    J Immunol; 1992 Dec; 149(11):3665-71. PubMed ID: 1385529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.
    Podack ER; Preissner KT; Müller-Eberhard HJ
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():89-96. PubMed ID: 6587746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SC5b-7, SC5b-8 and SC5b-9 complexes of complement: ultrastructure and localization of the S-protein (vitronectin) within the macromolecules.
    Preissner KP; Podack ER; Müller-Eberhard HJ
    Eur J Immunol; 1989 Jan; 19(1):69-75. PubMed ID: 2465906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
    Milis L; Morris CA; Sheehan MC; Charlesworth JA; Pussell BA
    Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes.
    Bhakdi S; Käflein R; Halstensen TS; Hugo F; Preissner KT; Mollnes TE
    Clin Exp Immunol; 1988 Dec; 74(3):459-64. PubMed ID: 2466593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of integrin receptors for laminin and type IV collagen on metastatic B16 melanoma cells.
    Ramos DM; Berston ED; Kramer RH
    Cancer Res; 1990 Feb; 50(3):728-34. PubMed ID: 2153445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
    Lehto T; Meri S
    J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of integrin-mediated adhesion at focal contacts by cyclic AMP.
    Glass WF; Kreisberg JI
    J Cell Physiol; 1993 Nov; 157(2):296-306. PubMed ID: 7693723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody inhibits adhesion to fibronectin and vitronectin of a colon carcinoma cell line and recognizes the integrins alpha v beta 3, alpha v beta 5, and alpha v beta 6.
    Lehmann M; Rabenandrasana C; Tamura R; Lissitzky JC; Quaranta V; Pichon J; Marvaldi J
    Cancer Res; 1994 Apr; 54(8):2102-7. PubMed ID: 7513610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of human osteoblasts to implant materials: integrin-mediated adhesion.
    Gronowicz G; McCarthy MB
    J Orthop Res; 1996 Nov; 14(6):878-87. PubMed ID: 8982129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell adhesion receptors for native and denatured type I collagens and fibronectin in rabbit arterial smooth muscle cells in culture.
    Yamamoto K; Yamamoto M
    Exp Cell Res; 1994 Sep; 214(1):258-63. PubMed ID: 7521843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma cell adhesion to basement membrane mediated by integrin-related complexes.
    Kramer RH; McDonald KA; Crowley E; Ramos DM; Damsky CH
    Cancer Res; 1989 Jan; 49(2):393-402. PubMed ID: 2535959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmembrane channel-formation by five complement proteins.
    Müller-Eberhard HJ
    Biochem Soc Symp; 1985; 50():235-46. PubMed ID: 2428370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terminal complement complex (TCC) and S-protein (vitronectin) on follicular dendritic cells in human lymphoid tissues.
    Halstensen TS; Mollnes TE; Brandtzaeg P
    Immunology; 1988 Oct; 65(2):193-7. PubMed ID: 2461343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex gangliosides modulate the integrin-mediated adhesion in a rat hepatoma cell line.
    Barletta E; Mugnai G; Ruggieri S
    Biochem Biophys Res Commun; 1993 Apr; 192(1):214-22. PubMed ID: 7682808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of thrombin-stimulated platelets with vitronectin (S-protein of complement) substrate: inhibition by a monoclonal antibody to glycoprotein IIb-IIIa complex.
    Thiagarajan P; Kelly K
    Thromb Haemost; 1988 Dec; 60(3):514-7. PubMed ID: 3238653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human melanoma cell attachment involves an Arg-Gly-Asp-directed adhesion receptor and the disialoganglioside GD2.
    Cheresh DA
    Prog Clin Biol Res; 1989; 288():3-24. PubMed ID: 2470110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-protein/vitronectin interaction with the C5b and the C8 of the complement membrane attack complex.
    Su HR
    Int Arch Allergy Immunol; 1996 Aug; 110(4):314-7. PubMed ID: 8768797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.